Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation

• Terence G. Hall ,

  * E-mail: thall@arqule.com

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯
• Yi Yu,

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯
• Sudharshan Eathiraj,

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯
• Yunxia Wang,

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯
• Ronald E. Savage,

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯
• Jean-Marc Lapierre,

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯
• Brian Schwartz,

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯
• Giovanni Abbadessa

  Affiliation ArQule, Inc., Burlington, MA, United States of America

  ⨯